Adrenergic alpha-2 Receptor Agonists
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Adrenergic alpha-2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
    
			
			
				
				
					
						| Descriptor ID | D058647 | 
					
						| MeSH Number(s) | D27.505.519.625.050.100.100.200 D27.505.696.577.050.100.100.200 | 
					
						| Concept/Terms | Adrenergic alpha-2 Receptor AgonistsAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha 2 Receptor AgonistsAdrenergic alpha2-AgonistsAdrenergic alpha2 Agonistsalpha2-Agonists, AdrenergicAdrenergic alpha-2 AgonistsAdrenergic alpha 2 AgonistsAgonists, Adrenergic alpha-2alpha-2 Agonists, AdrenergicAdrenergic alpha-2 Receptor AgonistAdrenergic alpha 2 Receptor Agonist
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-2 Receptor Agonists".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-2 Receptor Agonists".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Adrenergic alpha-2 Receptor Agonists" by people in this website by year, and whether "Adrenergic alpha-2 Receptor Agonists" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2002 | 0 | 1 | 1 | 
| 2007 | 1 | 0 | 1 | 
| 2014 | 1 | 0 | 1 | 
| 2017 | 1 | 0 | 1 | 
| 2018 | 0 | 1 | 1 | 
| 2021 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Adrenergic alpha-2 Receptor Agonists" by people in Profiles.
						
					
								- 
								a2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder. JAMA. 2021 05 25; 325(20):2067-2075. 
- 
								Endocrine Conditions in Older Adults: Menopause. FP Essent. 2018 Nov; 474:20-27. 
- 
								Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients. Crit Care Nurs Q. 2017 Oct/Dec; 40(4):344-362. 
- 
								Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):146-52. 
- 
								alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol. 2007 Oct 15; 584(Pt 2):437-50. 
- 
								Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.